Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Russian investigators describe new tranquilizer

Aug. 30, 1996

Flunitrazepam may alter circadian sleep-wake rhythms

Aug. 30, 1996

SDZ-266806: A novel squalene synthase inhibitor

Aug. 30, 1996

New agents for use in transplantation

Aug. 30, 1996

FR-173657: Fujisawa's bradykinin B2 antagonist

Aug. 23, 1996

UPF-596 described as a novel glutamate antagonist

Aug. 23, 1996

Eisai's squalene synthase inhibitor and prodrug

Aug. 23, 1996

KF-20444: Kyowa Hakko's novel antirheumatic agent

Aug. 23, 1996

Pfizer investigates enantiomeric profiles of citalopram, fluoxetine

Aug. 16, 1996

Lamotrigine, valproate tested in mood disorders

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...